Jazz Pharmaceuticals Plc Earnings

Jazz Pharmaceuticals Plc’s revenue jumped 6.74% since last year same period to $1126.11Mn in the Q3 2025. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 7.69% jump in its revenue since last 3-months.

Jazz Pharmaceuticals Plc’s net profit jumped 16.91% since last year same period to $251.41Mn in the Q3 2025. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 134.99% jump in its net profits since last 3-months.

Jazz Pharmaceuticals Plc’s net profit margin jumped 9.52% since last year same period to 22.33% in the Q3 2025. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 132.49% jump in its net profit margins since last 3-months.

Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current quarter stand at 5.96 - a 178.22% jump from last quarter’s estimates.

Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current year stand at 5.96.

Jazz Pharmaceuticals Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Jazz Pharmaceuticals Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.